US2005203600A1PendingUtilityA1

Collapsible/expandable tubular electrode leads

Assignee: SCIMED LIFE SYSTEMS INCPriority: Mar 12, 2004Filed: Mar 12, 2004Published: Sep 15, 2005
Est. expiryMar 12, 2024(expired)· nominal 20-yr term from priority
A61N 1/0553
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A medical lead and method of treating a patient are provided. The medical lead comprises an electrically insulative tubular membrane, a resilient spring element associated with the insulative membrane, and at least one electrode associated with the insulative membrane. In the preferred embodiment, the tubular membrane has a non-circular cross-sectional shape. The spring layer is configured to urge that insulative membrane into an expanded geometry. The medical lead is configured to be collapsed into a compact form for percutaneous delivery into the patient, thereby obviating the need to perform an invasive surgical procedure on the patient. The body formed by these elements, when expanded, can be sized to fit within the epidural space of a patient. The patient can be treated by placing the medical lead into a collapsed state by applying a compressive force to the medical lead, percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated, and placing the medical lead into an expanded state by releasing the compressive force. In one preferred method, the stimulation lead is used to stimulate tissue, such as spinal cord tissue.

Claims

exact text as granted — not AI-modified
1 . A medical lead, comprising: 
 an electrically insulative tubular membrane having an inner surface and an outer surface;    a resilient spring element associated with the insulative membrane; and    at least one electrode associated with the outer surface of the insulative membrane.    
     
     
         2 . The medical lead of  claim 1 , wherein the insulative membrane insulative membrane has a normally non-cylindrical shape.  
     
     
         3 . The medical lead of  claim 1 , wherein the insulative membrane has a first stiffness, and the spring layer has a second stiffness greater than the first stiffness.  
     
     
         4 . The medical lead of  claim 1 , wherein the insulative membrane is flaccid.  
     
     
         5 . The medical lead of  claim 1 , wherein the spring element is a discrete element.  
     
     
         6 . The medical lead of  claim 1 , wherein the spring element is a mesh or braid.  
     
     
         7 . The medical lead of  claim 1 , wherein the spring element is configured to expand the insulative membrane.  
     
     
         8 . The medical lead of  claim 1 , wherein the resilient spring element is associated with the outer surface of the insulative membrane.  
     
     
         9 . The medical lead of  claim 1 , wherein the resilient spring element is associated with the inner surface of the insulative membrane.  
     
     
         10 . The medical lead of  claim 1 , wherein the insulative membrane, spring element, and at least one electrode form a body that is configured to inhibit tissue growth.  
     
     
         11 . The medical lead of  claim 1 , wherein the insulative membrane, spring element, and at least one electrode form a body that is configured to be collapsed into a compact form for percutaneous delivery into a patient.  
     
     
         12 . The medical lead of  claim 1 , wherein the insulative membrane, spring element, and at least one electrode form an expanded body that is sized to fit within the epidural space of a patient.  
     
     
         13 . A method of performing a medical procedure on a patient, comprising: 
 placing the medical lead of  claim 1  into a collapsed state by applying a compressive force to the medical lead;    percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated; and    placing the medical lead into an expanded state by releasing the compressive force, whereby the resilient spring element facilitates expansion of the medical lead.    
     
     
         14 . The method of  claim 13 , further comprising stimulating the tissue with the medical lead.  
     
     
         15 . The method of  claim 13 , wherein the tissue is spinal cord tissue.  
     
     
         16 . A medical lead, comprising: 
 a resilient tubular structure having a normally non-circular cross-sectional shape; and    at least one electrode associated with the tubular structure.    
     
     
         17 . The medical lead of  claim 16 , wherein the tubular structure comprises a discrete resilient spring element.  
     
     
         18 . The medical lead of  claim 16 , wherein the tubular structure comprises a resilient mesh or braid.  
     
     
         19 . The medical lead of  claim 16 , wherein the tubular structure is configured to inhibit tissue growth.  
     
     
         20 . The medical lead of  claim 16 , wherein the tubular structure is configured to be collapsed into a compact form for percutaneous delivery into a patient.  
     
     
         21 . The medical lead of  claim 16 , wherein the tubular structure is sized to fit within the epidural space of a patient.  
     
     
         22 . The medical lead of  claim 16 , wherein the non-circular shape is a rectangle.  
     
     
         23 . The medical lead of  claim 16 , wherein the non-circular shape is an oval.  
     
     
         24 . The medical lead of  claim 16 , wherein the non-circular shape is a crescent-shaped.  
     
     
         25 . A method of performing a medical procedure on a patient, comprising: 
 placing the medical lead of  claim 16  into a collapsed state by applying an external force to the medical lead;    percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated; and    placing the medical lead into an expanded state by releasing the external force.    
     
     
         26 . The method of  claim 25 , further comprising stimulating the tissue with the medical lead.  
     
     
         27 . The method of  claim 26 , wherein the tissue is spinal cord tissue.

Join the waitlist — get patent alerts

Track US2005203600A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.